The ICU-recover Box, Using Smart Technology for Monitoring Health Status

Status Recruiting

Clinical Trial Summary

In this pilot study we will study the feasibility of providing and following ICU patients with smart technology for three months after discharge from a general ward of the Leiden University Medical Centre.

Clinical Trial Description

Rationale: Smart technology could improve quality of care in patients who have been admitted to the ICU and have been discharged from ICU and hospital, by early diagnosis of complications and early (ambulatory) treatment. In times of increasing medical care consumption leading to increasing health care costs the investigators have to adopt new ways of acquiring patient-specific knowledge and new ways of delivering care. To obtain this level of insight the investigators need a smart and connected health care system. With the ICU-Recover Box and its smart technology we see new opportunities to improve patient health and to recognise early if escalation of medical care is needed. By intervening early the investigators can reduce costs by reducing health care utilization. Objectives: The primary objective of the pilot study is to assess the feasibility of the introduction and use of smart technology by persons that have been discharged from the ICU in the three months following hospital discharge. If this pilot study proves to be successful, smart technology will be used in future studies. Study design: This is a single center cohort study. Study population: The study population consists of 15 patients who have been discharged from the ICU Department to a general ward of the Leiden University Medical Centre. Intervention: Patients who consent to take part in the study, receive an ICU-Recover Box closely before hospital discharge on the general ward. The ICU-Recover Box will contain a smartphone compatible blood pressure monitor, weight scale, and a watch containing a peripheral oxygen saturation monitor, a pedometer to monitor activity for home monitoring. Never will results of any of the measurements be used for therapy or diagnosis. Main study parameters/endpoints: The primary endpoint of the study will be the feasibility of providing and following ICU patients with smart technology for three months after discharge from a general ward of the Leiden University Medical Centre. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05766319
Study type	Interventional
Source	Leiden University Medical Center
Contact	Sesmu Arbous, MD PhD MSc
Phone	0626488225
Email	marbous@lumc.nl
Status	Recruiting
Phase	N/A
Start date	September 26, 2022
Completion date	August 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05539521` - Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Critically Ill Patients With Deep Sedation	Phase 2
Recruiting	`NCT04776486` - Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance	N/A
Recruiting	`NCT03231540` - The PREServation of MUScle Function in Critically Ill Patients (PRESMUS)	N/A
Completed	`NCT02286869` - Cardioventilatory Coupling in Critically Ill Patients	N/A
Completed	`NCT01434823` - 24 Hour Intensivist Coverage in the Medical Intensive Care Unit	N/A
Active, not recruiting	`NCT01142570` - Effect of Enteral Nutrition Enriched in Protein and Based on Indirect Calorimetry Measurement in Chronically Critically Ill Patients	N/A
Completed	`NCT01167595` - Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients	N/A
Completed	`NCT01293708` - Realities, Expectations and Attitudes to Life Support Technologies in Intensive Care for Octogenarians:
Not yet recruiting	`NCT00916591` - Prokinetic Drugs and Enteral Nutrition	N/A
Recruiting	`NCT00654797` - Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2	Phase 2
Withdrawn	`NCT00178321` - Improving Sleep in the Pediatric Intensive Care Unit	N/A
Completed	`NCT01168128` - PERFormance Enhancement of the Canadian Nutrition Guidelines by a Tailored Implementation Strategy: The PERFECTIS Study	N/A
Completed	`NCT02447692` - Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study	N/A
Recruiting	`NCT04582760` - Early Mobilization in Ventilated sEpsis & Acute Respiratory Failure Study	N/A
Not yet recruiting	`NCT05961631` - Bio-electrical Impedance Analysis Derived Parameters for Evaluating Fluid Accumulation
Completed	`NCT03276650` - Admission of Adult-onset Still Disease Patients in the ICU
Completed	`NCT03922113` - Muscle Function After Intensive Care
Recruiting	`NCT05055830` - Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
Recruiting	`NCT06027008` - Mechanical Insufflation-Exsufflation (Cough Assist) in Critically Ill Adults	N/A
Recruiting	`NCT05531253` - Respired Gases in Patients Post Cardiac Surgery

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The ICU-recover Box, Using Smart Technology for Monitoring Health Status After ICU Admission

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms